Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDELALISIB vs IMATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IDELALISIB vs IMATINIB: Safety Overview

Metric IDELALISIB IMATINIB
Total FAERS Reports 6,862 43,161
Deaths Reported 1,548 13,761
Death Rate 22.6% 31.9%
Hospitalizations 2,962 7,264
Average Patient Age 70.0 yrs 55.7 yrs
% Female Patients 38.4% 47.2%
FDA Approval Date Jul 23, 2014 Apr 14, 2025
Manufacturer Gilead Sciences, Inc. Dr.Reddy's Laboratories Inc
Route ORAL ORAL
Marketing Status Prescription Discontinued